Emily Paul

Biography
A molecular biologist with a specialty in genetics, Emily supports researchers and clinicians through the flagship product of SOPHiA GENETICS. The SOPHiA DDM™ platform democratizes data-driven medicine and enables precision medicine expertise in institutions of all sizes with multimodal data analysis and interpretation available to users at more than 780 labs and hospitals worldwide. Emily obtained her PhD at the State University of New York at Albany and was subsequently a fellow at Wadsworth Center at the New York State Department of Health, the Boston Children's Hospital, Harvard Medical School and the Dana-Farber Cancer Institute. She joined SOPHiA GENETICS in 2017 as a Subject Matter Expert. She is an enthusiastic mentor, collaborator and project leader who develops long-term productive relationships.

Clinical & Research Tools Showcase:
SOPHiA GENETICS
SOPHiA GENETICS is the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine. Our global platform allows healthcare professionals to leverage their expertise and work together around the world – unlocking the promise of data-driven medicine at scale.

Multimodality: A New Lens to Advance Precision Medicine
The sum of radiomics, genomics and biological data are made greater than their parts thanks to a multimodal approach. From biomarker discovery to patient stratification, learn how multimodality brings the future of precision medicine.